Mobile Barometer

Mobile Barometer
Mobile Barometer
Jen Mormile
SVP, Strategic ­Partnerships, Everyday Health

What mobile health trends have you seen over the past year? Where are the pharma dollars going?

The trend continues to be multi-channel marketing as the most effective way to continue a dialogue with both patients and physicians. Pharma marketing budgets are increasing in the mobile landscape. However, we hear that there are still some challenges in the market at large; once the industry overcomes a few obstacles and increases mobile-optimized sites and inadequate ISI real estate in the smaller, non-standard ad sizes, the ad revenue will increase dramatically.

Is the industry continuing to evolve in its understanding, focus and use of mobile? Where are you ­seeing innovation and what are the big challenges?

Patients are moving towards personalized condition management. They are engaging in tracking tools and demonstrate a deeper level of content consumption for disease state management on the go and on their smart phones. The most exciting innovation, I find, is the ability to have a synchronized message to consumers and the physicians who treat them. Physicians are relying heavily on their mobile device for quick, reliable medical news and information during the workday.

What will the next 12 months of mobile look like, as it pertains to your organization?

With the implementation of the Affordable Care Act, the physician's already strained workday will be pushed to the limits. Therefore they will need quick, reliable information to help make immediate treatment decisions. Patients have the ability to manage their conditions through mobile tracking tools and a breadth of searchable, encyclopedic information. Everyday Health will continue to take this approach to the next level by adding elements of personalization and feedback, and helping the patient comply and meet their health goals. 

Next: Michele Perras, Klick Health

Page 1 of 5
You must be a registered member of MMM to post a comment.

Next Article in Directories

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.